About Neuro-Sys
Neuro-Sys is a company based in Gardanne (France) founded in 2013 by Yann Jaudouin and Lucie Mottier. Neuro-Sys offers products and services including Preclinical Models, In Vitro Platform, and In Vivo Platform. Neuro-Sys operates in a competitive market with competitors including Wave Neuro, Cerca Insights, Afraxis, Nemosia and Rhenovia Pharma, among others.
- Headquarter Gardanne, France
- Founders Yann Jaudouin, Lucie Mottier
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuro-Sys Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$23.63 K (USD), Grant
Mar 01, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuro-Sys
Neuro-Sys offers a comprehensive portfolio of products and services, including Preclinical Models, In Vitro Platform, and In Vivo Platform.
Services for drug discovery in neurodegenerative diseases using in vivo models
Platform for in vitro studies of neuronal plasticity and disease mechanisms
Platform for animal-based testing in CNS and PNS disorders
People of Neuro-Sys
Unlock access to complete
Unlock access to complete
Funding Insights of Neuro-Sys
Investors in Neuro-Sys
Neuro-Sys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Neuro-Sys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuro-Sys
Investment portfolio details for Neuro-Sys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuro-Sys
Detailed financials for Neuro-Sys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuro-Sys Comparisons
Peer comparison for Neuro-Sys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuro-Sys
Neuro-Sys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wave Neuro, Cerca Insights, Afraxis, Nemosia and Rhenovia Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Preclinical services to neurological science are provided.
|
|
| Locked | Locked | Locked |
Provides preclinical services in behavioral pharmacology for research and development.
|
|
| Locked | Locked | Locked |
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
|
|
| Locked | Locked | Locked |
Preclinical services for neurological disorders are provided.
|
|
| Locked | Locked | Locked |
Biosimulation technology is provided for CNS drug discovery and development.
|
Detailed competitors of Neuro-Sys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuro-Sys
Complete news archive for Neuro-Sys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuro-Sys
Neuro-Sys was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Neuro-Sys is headquartered in Gardanne, France. It is registered at Gardanne, Bouches-du-rhone, France.
Yann Jaudouin is the current CEO of Neuro-Sys. They have also founded this company.
Neuro-Sys was founded in 2013 in Gardanne, France, as a preclinical contract research organization focused on the biotechnology sector. Primary cell cultures are provided for drug effect studies in CNS conditions such as Alzheimers, Parkinsons, Huntingtons, multiple sclerosis, peripheral neuropathies, and ALS. Blood-brain-barrier models are also supplied to assess drug penetration. Compounds from medicinal plants are identified and developed for neurodegenerative applications, alongside pharmacological and clinical services for nutraceutical projects.
Neuro-Sys's top competitors include Brains On-Line, Rhenovia Pharma and Brain Trust Bio.
Neuro-Sys offers Preclinical Models, In Vitro Platform, and In Vivo Platform.
Neuro-Sys has 1 investor. Key investors include European Union.